Large scale genetic association meta-analyses showed that neurocan (NCAN) gene polymorphism rs is susceptibility locus for bipolar disorder. Th ese studies also included patients with bipolar disorder originated from Bosnia and Herzegovina. Followed by theory of shared genetic elements between bipolar disorder and schizophrenia susceptibility, other studies explored several genetic factors with schizophrenia vulnerability as well. In this work, authors investigated the association between previously confi rmed bipolar disorder genetic risk factor-neurocan with schizophrenia in a population sample of Bosnia and Herzegovina. Ethical aspects of this research were assessed by Ethics Committee of Clinical Center University of Sarajevo. Blood samples for DNA extraction were taken from the total of  patients and healthy individuals who previously signed informed consent. Genotyping for rs  was done using direct sequencing method. A case-control analysis of common genetic polymorphism within neurocan gene and schizophrenia status in a consecutively sampled patient cohort have been done using Fisher-exact test with odds-ratio calculation. No statistically signifi cant allele and genotype association with disease status was found (p>.). Our fi nding supports the fact that large-scale genetic association studies approach need to be employed when detecting the variants with small additive eff ect in phenotypes with complex ethiology. 
INTRODUCTION
Classical genetic studies proved that schizophrenia is a highly heritable disease. Genetic make-up of this psychiatric disorder is being thoroughly explored for improvement of diagnostic methods and therapeutic targets. Although signifi cant research and technological eff orts were made, no gene was found to be pointed out as a single contributory genetic risk factor for development of disease or specifi c treatment responses in schizophrenia [-] . Underlying reason for that is quite clear from the investigator's point of view: schizophrenia is a complex polygenic trait with significant influence of non-genetic environmental factors. When genetic component of disease was dissected it became an inevitable fact that no single gene is suffi cient either necessary for onset and development of schizophrenia in stipulated polygenic model indicating more than - loci involved [] .
Extensive research work done globally derived the list of candidate genes for schizophrenia and bipolar disorder (BD) on which most of the genes were actually proved to be the shared genetic factors [-] . Th e most of the identifi ed gene eff ects could not be replicated in diff erent population samples [] . For the detection of common variants with small additive effects, generally the strategy of detection based on increased size of population sample and resolution of genomic arrays, followed by functional studies, represent the only rational approach applicable in genetic characterization of schizophrenia and other complex diseases. A recent study [] found genome-wide significant association between common variation in the gene neurocan (NCAN, rs) and BD. In view of accumulating evidence that BD and schizophrenia partly share genetic risk factors [] . Th is single-nucleotide polymorphism was tested for association with schizophrenia in three independent patient-control samples of European ancestry. Th e rs A-allele, which confers risk for BD, was significantly overrepresented in schizophrenia patients compared to controls (p = . ×  −  ; odds ratio = .). In this study we tested association of same locus (NCAN, rs) with schizophrenia patients originating from Bosnia and Herzegovina.
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MATERIALS AND METHODS
All procedures and methods used in this study were approved by Ethics Committee of Clinical Center of University of Sarajevo. Following informed consent process and relevant document signature, all participation of both patients and control individuals was voluntary. Diagnosis of schizophrenia was done based on DSM-IV corresponding structured clinical interview (SCID-I) done by single psychiatrist in all cases [] .
Patients
Healthy individuals free of family history of major psychiatric disorders (schizophrenia, bipolar disorder and depression) were included in this study.
Procedures
Blood specimens were collected from  patients and  healthy volunteers. Genetic material used for further analysis of NCAN locus and rs as informative site, was extracted from EDTA anticoagulated blood using salting out procedure [] . Based on FASTA sequence for 'UTR of neurocan gene obtained from NCBI, we designed the fl anking primers for rs: forward '-CATTGCCTGGTGGTCTAGAAA-' and reverse '-GGAGGAAGGCAAGGTGAGTT-'. For in vitro amplifi cation we used water solution of X PCR premix (REDTaq® ReadyMix™ PCR Reaction Mix, SIGMA-AL-DRICH) , ng of DNA template, pmol of each primer template in  μl total reaction volume. Reaction conditions were optimized as follows: initial denaturation step at °C for  minutes was followed by  cycles of denaturation at °C for  s, primer annealing for s at °C and extension at °C for  min, final elongation at °C for  minutes and unlimited hold at °C. Genotype detection was done on ABI  followed by BigDye terminator single primer ('-CATTGCCTGGTGGTC-TAGAAA-') extension reaction. Automatically obtained sequences were read manually for exclusion of false homozygotes.
Statistical analysis
Generated genotype data were collected for further statistical analysis using Fisher-exact test with odds-ratio calculation as a part of Powermarker [] and MedCalc software for Windows, version ... (MedCalc Software, Mariakerke, Belgium).
RESULTS
Total of  individuals ( patients and  healthy volunteers) were genotyped for rs using direct sequencing method. All three expected genotypes: GG, AG and AA were observed ( Figure ) . Four genotype data from control group could not be used for further statistical analysis due to low quality of DNA electropherograms. Hardy-Weinberg Equilibrium (HWE) test showed that case group data subset was in the range of expected frequency distribution (p=.) supporting the quality of procedures of sampling and genotyping. In case group, among  observed genomes, thirteen minor allele variants (A) were detected (. ) as for in control group out of  genomes five minor alleles were found (. ). All expected genotypes (AA, AG and GG) were observed in all cases (Table  ) with relative frequencies . , .  and .  respectively in case and  , .  and .  in control group. A case-control analysis of common genetic polymorphism within NCAN gene and schizophrenia status has been done using Fisher-exact test with odds-ratio calculation. No statistically significant allele association with disease status was found (Exact p value=., OR=. with p=.). Association analysis for genotype frequencies distributions between two analyzed groups was also negative (Exact p- value >.). Re-sampling with  iterations showed no diff erence between artifi cially generated and actual sample.
DISCUSSION
A risk conferring allele A at locus rs of NCAN was analysed in terms of its engagement in pathophysiology of bipolar disorder in a sample comprised of several subsets of European descent subpopulations including Bosnian and Herzegovinian with rs A allele overrepresentation of  in cases versus  in controls and OR =. and p<.. Meta-analysis of pooled population data undoubtedly confi rmed genetic association of NCAN structure variation with actual disease state [] . Driven by previously and scientifi cally supported hypothesis of schizophrenia and bipolar disorder shared pathophysiology in rather large population datasets of more than  patients and  controls [] confi rmed the genetic association of minor A-ellele at locus rs with OR of at least . and p=.. Both fi ndings implicate that person who carries at least one copy of A allele has an increased risk for development of disease, namely . times more in schizophrenia and . times more in bipolar disorder in relation to major allele carriers. In our study of genetic association of rs we observed a diff erence in distribution of minor allele frequencies between patients and control individuals that was not statistically signifi cant (p>.). Risk allele is overrepresented in a case group (. ) versus control group (. ) indicating the signifi cance of this variant in a genetic make-up of a disease (OR=. with p=.). Th e statistical insignifi cance of observed diff erences could be largely due to investigated population size but lack of association results in our sample cannot be completely overruled for this reason since re-sampling statistical procedures suggest that sample size of investigated groups possibly had no eff ect on fi nal results of genetic association. As common risk variant NCAN gene has small eff ect size in polygenic model of schizophrenia unable to reach statistical significance in some association studies. Th is is the main reason why in some independent studies described before [] lack of association was observed. However in meta-analysis of the same independent schizophrenia samples statistical signifi cance was reached at p=. [] but not even close as for bipolar disorder p=.x - [] . Th erefore, fi ndings related to BP [] and schizophrenia samples from Bosnia and Herzegovina as well as in other populations [, , ] implicate that allele A at neurocan locus rs is more frequently represented in etiopatology of bipolar disorder than of schizophrenia.
CONCLUSIONS
In this study we found no genetic association between risk allele A for NCAN locus rs and schizophrenia. Tests for HWE showed that both population subsets are in equilibrium which contributes to the quality of sampling and technical procedures during the study. Any disequilibrium that could drive to false positive association findings was eliminated. Independent studies worldwide that investigated genetic relatedness of neurocan with schizophrenia had indecisive outputs. Suggestive overrepresentation of risk alleles was found but no observable statistical significance with standard statistical methods for genetic association analysis was reached. Only in large meta-analyses, small additive effect of NCAN could be detected. Our fi nding supports the fact that large-scale genetic association studies approach need to be employed when detecting the variants with small additive eff ect in phenotypes with complex etiology. 
